Jan. 4 at 2:03 PM
$ECLMF secures
$1 million in additional funding from controlling shareholder. Plans to convert previous loans of
$3,498,853 into voting common shares at a discounted price of 13.50 cents, pending TSX Venture Exchange approval. Extra
$1 million to support commercialization activities at the Hawkesbury facility.